ScinoPharm Taiwan is a process research, development and manufacturing service provider to the global pharmaceutical industry specializing in Active Pharmaceutical Ingredients (API), related intermediates and clinical supplies. Its state-of-the-art pharmaceutical process R&D and manufacturing facilities are one of the largest stand-alone non-Brand, multi-product API operations in the world. Its primary business focus includes: Custom Synthesis for early phase pharmaceutical activities Generic API manufacturing Brand company outsourcing services. Combining cost-effective resources and productivity of Asia along with unmatched regulatory know-how, ScinoPharm is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector.
